With 104 Rare Diseases related patents published between 2002 and 2022, Pfizer Inc holds the most number of Rare Diseases patents in Algeria, of which 47.1% was contributed by its subsidiary Pfizer Products Inc..
The second largest number of Rare Diseases related patents were published by GSK plc with 26 patents. The third largest number of Rare Diseases related patents were published by GlaxoSmithKline Plc with 15 patents. The fourth largest number of Rare Diseases related patents were published by Eli Lilly and Co with 10 patents. The fifth largest number of Rare Diseases related patents were published by Merck & Co Inc with 10 patents.
The top five patent holders, i.e., Pfizer Inc, GSK plc, GlaxoSmithKline Plc, Eli Lilly and Co, and Merck & Co Inc, together held 165 Rare Diseases patents during the period.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer